| Current Epidemiology, Pathophysiology, and Risk Factors in Retinopathy of Prematurity | Pehmen Yasin ÖZCAN,MEHMET ÇITIRIK,Şehnaz ÖZÇALIŞKAN | 263–270 |
| Current Classification, Screening, Examination Methods, and Treatment in Retinopathy of Prematurity | Pehmen Yasin ÖZCAN,MEHMET ÇITIRIK | 271–279 |
| The Relationship Between Retinal Vein Occlusions and ABO (H) Blood Groups | Mustafa GÖK,Aslıhan UZUN,Hasan Burhanettin KAPTI,Özgür KARA | 280–284 |
| The Prevalence of Congenital Color Vision Defect in the Young Healty Turkish Males | Sami TOYRAN,Fahrettin AKAY,Musa SALMANOĞLU,Faruk YEŞİLTAŞ | 285–288 |
| Fundus Otoflöresans Görüntüleme Yöntemi ile Stargardt-Fundus Flavimakulatus Hastalığı'nın Farklı Fenotipik Özelliklerinin ve Progresyonunun Değerlendirilmesi | Pınar KIZILTUNÇ BİNGÖL,FİGEN ŞERMET,SİBEL DEMİREL,Emin ÖZMERT | 289–292 |
| Anatomical Success of Combined Scleral Buckle and Pneumatic Retinopexy in Primary Retinal Detachment Surgery | Arief KARTASASMİTA,Ratu Puri SASTRADİWİRJA2,Rova VIRGANA,Erwin ISKANDAR,Iwan SOVANİ,Djonggi PANGGABEAN | 293–296 |
| Management of Sub Macular Hemorrhage with Intravitreal Injection of Tissue Plasminogen Activator and Sulfur Hexafluoride | Bodhraj DHAWAN,Vipin VIG,Preetam SINGH,Rajbir SINGH | 297–300 |
| The Effects of Low Dose Acetylsalicylic Acid on Treatment and Recurrence of Acute Central Serous Chorioretinopathy | Mustafa ELİAÇIK,SEVİL KARAMAN ERDUR,Cemile Anıl ASLAN,Fevzi ŞENTÜRK,Cengiz ARAS,Faruk KAYA | 301–304 |
| The Relationship Between Optical Coherence Tomography Results and Visual Acuity in Patients with Diabetic Retinopathy | Mustafa VATANSEVER,Özlem YILDIRIM,ÖZER DURSUN,Ayça YILMAZ,ERDEM DİNÇ,UFUK ADIGÜZEL,Gülhan Ö. TEMEL | 305–308 |
| Effect of Foveal Cyst Size on the Visual Prognosis in Diabetic Macular Edema | Durgül AÇAN,Mahmut KAYA,ARİF TAYLAN ÖZTÜRK,ZİYA AYHAN,Süleyman KAYNAK,Nilüfer KOÇAK | 309–312 |
| Efficacy and Safety of Intra-vitreal Bevacizumab (Avastin®) Using Pro Re Nata Regimen in Treatment of Macular Edema Due to Retinal Vein Occlusion |